Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Sohn

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2021
A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysisA Brufsky, S B Kim, Ž Zvirbule, et al.
Histopathology|December 21, 2002
Association of maspin expression with the high histological grade and lymphocyte-rich stroma in early-stage breast cancerD H Kim, D S Yoon, W C Dooley, et al.
Diabetes & Metabolism|November 6, 2016
A prospective study of leucocyte mitochondrial DNA content and deletion in association with the metabolic syndromeJ-Y Kim, J R Choi, I H Park, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 27, 2007
Gene amplification and protein overexpression of HER-2/neu in human extrahepatic cholangiocarcinoma as detected by chromogenic in situ hybridization and immunohistochemistry: its prognostic implication in node-positive patientsH J Kim, T W Yoo, D I Park, et al.
Alimentary Pharmacology & Therapeutics|August 1, 2014
Relative adrenal insufficiency in chronic liver disease: its prevalence and effects on long-term mortalityJ Y Jang, T Y Kim, J H Sohn, et al.
British Journal of Cancer|October 28, 2005
Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neckJ G Kim, S K Sohn, D H Kim, et al.
Journal of Korean Medical Science|January 14, 1999
Combination chemotherapy of oral 5'-deoxy-5-fluorouridine and cisplatin in advanced gastric cancer: a phase II studyM J Ahn, D S Han, J H Sohn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2013
Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905)H R Kim, K H Jung, S-A Im, et al.
Cancer Research and Treatment|December 19, 2015
Efficacy of Pre- and Postoperative Chemotherapy in Patients with Osteosarcoma of the ExtremitiesJ H Sohn, S Y Rha, H C Jeung, et al.
Investigational New Drugs|May 17, 2013
A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancerK H Park, J H Sohn, S Lee, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2021
A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysisA Brufsky, S B Kim, Ž Zvirbule, et al.
Histopathology|December 21, 2002
Association of maspin expression with the high histological grade and lymphocyte-rich stroma in early-stage breast cancerD H Kim, D S Yoon, W C Dooley, et al.
Diabetes & Metabolism|November 6, 2016
A prospective study of leucocyte mitochondrial DNA content and deletion in association with the metabolic syndromeJ-Y Kim, J R Choi, I H Park, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 27, 2007
Gene amplification and protein overexpression of HER-2/neu in human extrahepatic cholangiocarcinoma as detected by chromogenic in situ hybridization and immunohistochemistry: its prognostic implication in node-positive patientsH J Kim, T W Yoo, D I Park, et al.
Alimentary Pharmacology & Therapeutics|August 1, 2014
Relative adrenal insufficiency in chronic liver disease: its prevalence and effects on long-term mortalityJ Y Jang, T Y Kim, J H Sohn, et al.
British Journal of Cancer|October 28, 2005
Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neckJ G Kim, S K Sohn, D H Kim, et al.
Journal of Korean Medical Science|January 14, 1999
Combination chemotherapy of oral 5'-deoxy-5-fluorouridine and cisplatin in advanced gastric cancer: a phase II studyM J Ahn, D S Han, J H Sohn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2013
Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905)H R Kim, K H Jung, S-A Im, et al.
Cancer Research and Treatment|December 19, 2015
Efficacy of Pre- and Postoperative Chemotherapy in Patients with Osteosarcoma of the ExtremitiesJ H Sohn, S Y Rha, H C Jeung, et al.
Investigational New Drugs|May 17, 2013
A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancerK H Park, J H Sohn, S Lee, et al.
Pageof 9